Infinity Pharmaceuticals | INFI - Trade Creditors


Infinity Pharmaceuticals reported $1.5M in Trade Creditors for its fiscal quarter ending in June of 2023.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Cipla INR 32.3B 1.95B Mar/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Eisai JPY 75.89B 9.6B Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Grifols EUR 987.75M 47.87M Dec/2025
Incyte USD 228.62M 1.41B Mar/2026
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Plus Therapeutics 5.92M 5.7M Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
TG Therapeutics USD 148.84M 41.34M Mar/2026